Research Project:
C309/A11566
C309/A11566
Contributors
Funders
ID
http://dx.doi.org/10.13039/501100000289
Authors
Person
Publications
Publication
Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation
(American Association for Cancer Research,
05/04/16)
Organizational Units
Organizational Unit
Description
Cancer Research UK